Scientists at the University of Leeds have discovered that targeting a protein that helps cancer cells repair their DNA could lead to a new treatment for the highly aggressive brain tumour, glioblastoma (GBM).

Claire Lloyd came across our HeadSmart website, which lists the most common signs of childhood brain tumours, after her nine-year-old son Jack had been vomiting regularly during the day for more than a week.

David Jenkinson, Chief Scientific Officer at The Brain Tumour Charity, discusses laying foundations for more effective brain tumour treatments.

HeadSmart has already helped cut the average diagnosis time for a childhood brain tumour in the UK from more than 13 weeks to 6.5 weeks.

A combinatorial approach using immunotherapy and gene therapy has been explored by researchers at the University of Michigan against the highly aggressive brain tumour, glioblastoma (GBM).

The Brain Tumour Charity have collaborated with NHS England to better understand the role of Clinical Nurse Specialists (CNS) and Keyworkers who work with people affected by brain tumours.

In response to overwhelming concerns from our community The Brain Tumour Charity met with the Driver and Vehicle Licensing Agency (DVLA) in Swansea to discuss issues around driving and brain tumours.

A team at The Scripps Research Institute, USA, have been able to identify a cellular pathway used by glioblastoma (GBM) tumours to allow them to survive, that could be exploited therapeutically to halt tumour growth.

Grace, 23, recently filmed her first video blog for us where she asked our community for any questions about diagnosis, symptoms and effects and life after surgery. Her honest and heartfelt answers are now documented in a video diary.

A report today from Cancer Research UK predicts that survival from brain tumours will remain virtually unchanged over the next 20 years, despite an expected fall of 15% overall in the number of cancer deaths by 2035.

Dr Paul Brennan, from the University of Edinburgh, shares a round-up of his research with us.

The Biobanking Consensus Meeting, initiated by us, is being held at Islington’s Business Design Centre in London.

Researchers from Toronto and Montreal have successfully identified three distinct sub-groups of classification of the incurable typical teratoid rhabdoid tumours (ATRTs).

A drug that can extend the lives of brain tumour patients is being withheld by some NHS Trusts on the grounds of cost.

In order to ensure that we fund only the highest quality research, we have formed two Scientific Advisory Boards (SABs) which are made up of internationally renowned scientific and medical experts that work in different areas of cancer research and social science.

Beccy Shortt, our Senior Policy and Public Affairs Manager at The Brain Tumour Charity explores the barriers surrounding brain tumour research.

Researchers at the University of Texas Southwestern Medical Center in Dallas have identified a gene called SHOX2 that could be used to better diagnose brain tumours.

“We will always do things differently if it’s the right thing for people affected by a brain tumour. That’s why we’re investing in The Brain Tumour Fund.” – Sarah Lindsell, CEO of The Brain Tumour Charity

Julien Baptiste’s character, played by acclaimed actor Tchéky Karyo, steered the second series of the award-winning drama with the diagnosis of a brain tumour framing his actions and decisions as a key aspect of the storyline.

Lewis Moody MBE, co-Founder of The Foundation and headeast organiser, polar explorer Alan Chambers MBE and 10 other fearless cycling challengers have saddled up in Saigon.

Research carried out at the University of Edinburgh has revealed a new alliance between immune cells and glioblastoma tumour cells in zebrafish.

Patients diagnosed with cancer should be told clearly how the NHS will store and use information about their case to help others in future, says a new report.

Our Director of Services and Influencing, Emma Tingley, shares her thoughts on navigating the system after a brain tumour diagnosis, and our recently launched Patient Guide.

A battery-powered cap that disrupts the growth of brain tumour cells could help glioblastoma patients to survive for longer, new findings suggest.